The glucose monitoring devices market was valued at USD 13,154 million in 2024. The market is projected to reach USD 20,080.85 million by 2032. Growth is expected at a CAGR of 5.43% during the forecast period.
REPORT ATTRIBUTE
DETAILS
Historical Period
2020-2023
Base Year
2024
Forecast Period
2025-2032
Glucose Monitoring Devices Market Size 2024
USD 13,154 million
Glucose Monitoring Devices Market, CAGR
5.43%
Glucose Monitoring Devices Market Size 2032
USD 20,080.85 million
Glucose Monitoring Devices Market Insights
Rising diabetes prevalence, aging populations, and emphasis on regular self-monitoring fuel glucose monitoring devices market growth worldwide.
Self-monitoring blood glucose devices lead with a 58% segment share, supported by affordability, ease of use, and wide availability.
Competition centers on accuracy, sensor longevity, mobile connectivity, and reimbursement access, while cost pressures restrain premium adoption.
North America leads with a 37% regional share, followed by Europe at 29% and Asia Pacific at 24%, reflecting healthcare access, guideline-driven testing, and growing homecare monitoring.
Self-monitoring blood glucose devices lead the glucose monitoring devices market with a 58% segment share. Widespread availability and affordability support strong adoption. Patients rely on fingerstick testing for routine glucose checks. Clinical familiarity strengthens physician recommendations. Insurance coverage supports consistent usage. Continuous glucose monitoring devices hold a 42% share, driven by real-time tracking and improved glycemic control. SMBG devices dominate due to lower costs and ease of access. High diabetes prevalence sustains daily testing needs. Ongoing device accuracy improvements further support SMBG demand across home and clinical settings.
For instance, Roche Diagnostics’ Accu-Chek Guide system delivers laboratory-aligned accuracy within ±10 mg/dL at low glucose ranges, based on ISO 15197:2013 standards.
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research Inc.!
Invasive monitoring dominates with a 73% market share in the glucose monitoring devices market. Proven accuracy and regulatory approval support strong trust. Fingerstick and sensor-based methods remain clinical standards. Non-invasive monitoring accounts for a 27% share, driven by patient comfort and reduced pain. Technology maturity limits large-scale adoption for non-invasive options. Invasive dominance reflects reliability and established reimbursement. Healthcare providers prioritize precise readings for treatment decisions. Continuous improvements in sensor comfort and lifespan further reinforce invasive monitoring leadership.
For instance, Dexcom’s G7 CGM system uses a 10-day wearable sensor with an automated applicator that inserts the filament in under one second, improving placement consistency and user comfort.
By End User
Homecare settings represent the largest end-user segment with a 61% market share. Rising self-management of diabetes supports home use. User-friendly devices enable frequent monitoring. Growing elderly population increases homecare reliance. Hospitals and clinics hold a 39% share, driven by diagnosis and treatment initiation. Homecare dominance reflects shift toward patient-centered care. Telehealth integration supports remote monitoring. Convenience and cost savings strengthen adoption in home environments. Long-term disease management trends continue driving demand in homecare settings.
Key Growth Drivers
Rising Global Prevalence of Diabetes
Diabetes prevalence continues increasing across all age groups. Lifestyle changes and aging populations raise disease incidence. Regular glucose monitoring remains essential for disease management. Physicians emphasize frequent testing to prevent complications. Homecare adoption supports daily monitoring routines. Early diagnosis increases device usage rates. Public health programs promote screening initiatives. Urbanization influences dietary habits and diabetes risk. This driver sustains consistent demand for glucose monitoring devices across developed and emerging healthcare systems.
For instance, Abbott Laboratories reports that its FreeStyle Libre systems generate one glucose reading every minute, producing 1,440 readings per day per user, supporting tighter glycemic tracking.
Shift Toward Self-Monitoring and Homecare Management
Patients increasingly manage diabetes at home. User-friendly devices simplify daily glucose tracking. Homecare reduces hospital visits and treatment costs. Telehealth integration supports remote data sharing. Elderly patients benefit from convenient monitoring solutions. Caregivers rely on easy-to-use devices. Insurance coverage supports home-based testing. Patient education improves compliance. This driver accelerates demand for personal glucose monitoring devices globally.
For instance, Roche Diagnostics’ Accu-Chek Instant meter delivers test results in under 4 seconds and stores up to 720 readings with date and time stamps, improving long-term monitoring continuity.
Technological Advancements in Monitoring Accuracy
Device accuracy improves with sensor innovation. Enhanced calibration reduces measurement errors. Faster result delivery supports timely treatment decisions. Continuous monitoring improves glycemic control. Data connectivity enables trend analysis. Software integration supports personalized care plans. Manufacturers invest in R&D continuously. Improved reliability builds patient and physician trust. This driver strengthens adoption across both clinical and homecare environments.
Key Trends & Opportunities
Growth of Continuous Glucose Monitoring Adoption
Continuous monitoring gains acceptance among patients. Real-time alerts improve safety and compliance. Reduced fingerstick testing enhances comfort. Integration with mobile apps improves usability. Physicians value continuous data insights. Pediatric and insulin-dependent patients show strong adoption. Technology upgrades extend sensor life. This trend creates strong opportunities for premium device expansion.
For instance, Dexcom’s G7 system captures glucose readings every 5 minutes, generating 288 data points per day to support detailed glycemic profiling.
Integration with Digital Health Platforms
Devices connect seamlessly with smartphones and wearables. Cloud-based data sharing supports remote care. AI-driven analytics enhance glucose insights. Digital dashboards improve patient engagement. Healthcare providers access real-time data. Personalized alerts support lifestyle adjustments. This trend opens opportunities for data-driven diabetes management solutions.
For instance, Medtronic’s Guardian Connect platform uploads glucose data automatically to CareLink software, enabling clinicians to review up to 30 days of continuous readings per patient session.
Key Challenges
High Cost of Advanced Monitoring Devices
Advanced devices carry higher upfront costs. Limited reimbursement affects accessibility. Cost sensitivity remains high in emerging markets. Sensor replacement adds recurring expenses. Budget constraints limit adoption. Pricing pressure affects manufacturer margins. This challenge slows penetration of premium glucose monitoring technologies.
Accuracy and Reliability Concerns in New Technologies
New monitoring methods face validation challenges. Inconsistent readings reduce user confidence. Environmental factors affect performance. Regulatory approval timelines remain lengthy. Clinical acceptance requires extensive testing. Device calibration increases complexity. This challenge delays adoption of next-generation monitoring solutions.
Regional Analysis
North America
North America holds a 37% market share in the glucose monitoring devices market. High diabetes prevalence drives routine monitoring demand. Strong insurance coverage supports device access. Continuous glucose monitoring adoption remains high among insulin users. Digital health integration improves care coordination. Homecare monitoring dominates usage patterns. Robust regulatory frameworks ensure device reliability. Innovation pipelines remain active across leading manufacturers. The United States leads regional demand due to advanced healthcare infrastructure and strong patient education programs.
Europe
Europe accounts for a 29% market share in the glucose monitoring devices market. Public healthcare systems support broad access to monitoring tools. Aging populations increase diabetes management needs. Clinical guidelines promote regular testing. Continuous monitoring grows steadily through reimbursement expansion. Pharmacies and clinics serve as key distribution points. Regulatory emphasis ensures quality and safety. Western Europe drives volume through established care pathways and technology adoption.
Asia Pacific
Asia Pacific represents a 24% market share in the glucose monitoring devices market. Rapid urbanization raises diabetes incidence. Large patient populations drive volume demand. Homecare adoption grows with awareness programs. Cost-effective SMBG devices dominate usage. Digital platforms expand access and education. Government initiatives improve screening rates. China and India contribute significantly due to scale and improving healthcare access.
Rest of the World
The rest of the world holds a 10% market share in the glucose monitoring devices market. Latin America and the Middle East lead regional demand. Public health initiatives support screening and monitoring. Price sensitivity influences device choice. SMBG remains the primary method. Distribution improves through pharmacies and clinics. Gradual reimbursement expansion supports adoption. Growth opportunities rise as awareness and access improve.
Glucose Monitoring Devices Market Segmentations:
By Product Type
Self-monitoring blood glucose devices
Continuous glucose monitoring devices
By Technology
Invasive monitoring
Non-invasive monitoring
By End User
Hospitals and clinics
Homecare settings
By Geography
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
South-east Asia
Rest of Asia Pacific
Latin America
Brazil
Argentina
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of the Middle East and Africa
Competitive Landscape
Competitive landscape analysis highlights Abbott Laboratories, Dexcom, Medtronic, Roche Diagnostics, and Ascensia Diabetes Care as leading participants in the glucose monitoring devices market. These companies compete through technology innovation, product accuracy, and strong global distribution. Market leaders focus on continuous glucose monitoring systems with real-time alerts and data connectivity. Integration with mobile apps and digital health platforms strengthens differentiation. Established players leverage reimbursement coverage and clinician trust to defend market share. Ongoing investment in sensor longevity and user comfort improves adoption. Strategic partnerships with digital health providers expand ecosystem capabilities. Competitive pressure remains high as companies balance affordability with advanced features. Regulatory compliance, data reliability, and patient outcomes remain critical factors shaping competitive positioning across global markets.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
In April 2025, Dexcom received U.S. FDA clearance for the Dexcom G7 15-Day Continuous Glucose Monitoring (CGM) System.
In 2024, Roche Diagnostics maintained efforts to enhance connected glucose monitoring, continuing integration of blood glucose data with digital management platforms and apps.
Report Coverage
The research report offers an in-depth analysis based on Product Type,Technology, End User and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.
1. Introduction
1.1. Report Description
1.2. Purpose of the Report
1.3. USP & Key Offerings
1.4. Key Benefits for Stakeholders
1.5. Target Audience
1.6. Report Scope
1.7. Regional Scope 2. Scope and Methodology
2.1. Objectives of the Study
2.2. Stakeholders
2.3. Data Sources
2.3.1. Primary Sources
2.3.2. Secondary Sources
2.4. Market Estimation
2.4.1. Bottom-Up Approach
2.4.2. Top-Down Approach
2.5. Forecasting Methodology 3. Executive Summary 4. Market Introduction
4.1. Overview
4.2. Key Industry Trends 5. Global Glucose Monitoring Devices Market
5.1. Market Overview
5.2. Market Performance
5.3. Impact of COVID-19
5.4. Market Forecast 6. Market Breakup by Product Type
6.1. Self-Monitoring Blood Glucose Devices
6.1.1. Market Trends
6.1.2. Market Forecast
6.1.3. Revenue Share
6.1.4. Revenue Growth Opportunity
6.2. Continuous Glucose Monitoring Devices
6.2.1. Market Trends
6.2.2. Market Forecast
6.2.3. Revenue Share
6.2.4. Revenue Growth Opportunity 7. Market Breakup by Technology
7.1. Invasive Monitoring
7.1.1. Market Trends
7.1.2. Market Forecast
7.1.3. Revenue Share
7.1.4. Revenue Growth Opportunity
7.2. Non-Invasive Monitoring
7.2.1. Market Trends
7.2.2. Market Forecast
7.2.3. Revenue Share
7.2.4. Revenue Growth Opportunity 8. Market Breakup by End User
8.1. Hospitals and Clinics
8.1.1. Market Trends
8.1.2. Market Forecast
8.1.3. Revenue Share
8.1.4. Revenue Growth Opportunity
8.2. Homecare Settings
8.2.1. Market Trends
8.2.2. Market Forecast
8.2.3. Revenue Share
8.2.4. Revenue Growth Opportunity 9. Market Breakup by Region
9.1. North America
9.1.1. United States
9.1.1.1. Market Trends
9.1.1.2. Market Forecast
9.1.2. Canada
9.1.2.1. Market Trends
9.1.2.2. Market Forecast
9.2. Asia-Pacific
9.2.1. China
9.2.2. Japan
9.2.3. India
9.2.4. South Korea
9.2.5. Australia
9.2.6. Indonesia
9.2.7. Others
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. United Kingdom
9.3.4. Italy
9.3.5. Spain
9.3.6. Russia
9.3.7. Others
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Others
9.5. Middle East and Africa
9.5.1. Market Trends
9.5.2. Market Breakup by Country
9.5.3. Market Forecast 10. SWOT Analysis
10.1. Overview
10.2. Strengths
10.3. Weaknesses
10.4. Opportunities
10.5. Threats 11. Value Chain Analysis 12. Porter’s Five Forces Analysis
12.1. Overview
12.2. Bargaining Power of Buyers
12.3. Bargaining Power of Suppliers
12.4. Degree of Competition
12.5. Threat of New Entrants
12.6. Threat of Substitutes 13. Price Analysis 14. Competitive Landscape
14.1. Market Structure
14.2. Key Players
14.3. Profiles of Key Players
14.3.1. Abbott Laboratories
14.3.2. Dexcom
14.3.3. Medtronic
14.3.4. Roche Diagnostics
14.3.5. Ascensia Diabetes Care
14.3.6. LifeScan
14.3.7. Senseonics
14.3.8. Ypsomed
14.3.9. B. Braun
14.3.10. ARKRAY 15. Research Methodology
Request A Free Sample
We prioritize the confidentiality and security of your data. Our promise: your information remains private.
Ready to Transform Data into Decisions?
Request Your Sample Report and Start Your Journey of Informed Choices
Providing the strategic compass for industry titans.
Frequently Asked Questions:
What is the current market size for Glucose Monitoring Devices market, and what is its projected size in 2032?
The Glucose Monitoring Devices market size was USD 13,154 million in 2024 and is projected to reach USD 20,080.85 million by 2032.
At what Compound Annual Growth Rate is the Glucose Monitoring Devices market projected to grow between 2024 and 2032?
The Glucose Monitoring Devices market is projected to grow at a CAGR of 5.43% during the forecast period.
Which Glucose Monitoring Devices market segment held the largest share in 2024?
Self-monitoring blood glucose devices held the largest share in the Glucose Monitoring Devices market in 2024.
What are the primary factors fueling the growth of the Glucose Monitoring Devices market?
The Oral Macromolecular Formulation market size was valued at USD 9 million in 2024 and is projected to reach USD 12.51 million by 2032, reflecting a CAGR of 4.8% during the forecast period.
The implantable defibrillator market was valued at USD 4,394.5 million in 2024 and is expected to reach USD 7,164.33 million by 2032, growing at a CAGR of 6.3% during the forecast period.
The Ineffective Esophageal Motility Treatment market size was valued at USD 4,680 million in 2024 and is projected to reach USD 7,402.47 million by 2032, growing at a CAGR of 5.9% during the forecast period.
Erucamide market size was valued at USD 264 million in 2024 and is projected to reach USD 359.25 million by 2032, reflecting a CAGR of 3.93% during the forecast period.
The Cervical Cancer Screening market was valued at USD 1,557.00 million in 2024 and is anticipated to reach USD 2,444.5 million by 2032, registering a CAGR of 5.8% during the forecast period.
At Home Pregnancy Testing market size was valued at USD 730.5 million in 2024 and is anticipated to reach USD 1,007.5 million by 2032, growing at a CAGR of 4.1% during the forecast period.
At Home Molecular Testing market size was valued at USD 10,809 million in 2024 and is anticipated to reach USD 16,463.2 million by 2032, growing at a CAGR of 5.4% during the forecast period.
The Anti-Hyperglycemic Agents market size stood at USD 91,333 million in 2024. Analysts expect the market value to rise to USD 128,893.4 million by 2032. The industry is set to grow at a CAGR of 4.4% during the forecast period.
The Automated Microscopy market size reached USD 8,095 million in 2024 and is expected to reach USD 13,128.3 million by 2032, expanding at a CAGR of 6.23% during the forecast period.
The Clinical Rollators market size reached USD 2,016 million in 2024 and is projected to reach USD 3,760.07 million by 2032, advancing at a CAGR of 8.1% during the forecast period.
The wound filler market was valued at USD 607.5 million in 2024 and is expected to reach USD 844.3 million by 2032, growing at a CAGR of 4.2% during the forecast period.
The Smart Wheelchair market was valued at USD 177.5 million in 2024 and is anticipated to reach USD 333.4 million by 2032, growing at a CAGR of 8.2% during the forecast period.
Licence Option
The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing. Use restricted to one purchaser only.
$4999
To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis. Unlimited users allowed within one corporate location (e.g., regional office).
$5999
The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc. research team. Permitted for unlimited global use by all users within the purchasing corporation, such as all employees of a single company.
Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.
Materials Scientist (privacy requested)
The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.
